These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11074567)

  • 1. Increased levels of soluble tumor necrosis factor receptors in patients with aplastic anemia and myelodysplastic syndrome.
    Shinohara K; Muraki K; Ota I; Nawata R; Oeda E; Takahashi T
    Am J Hematol; 2000 Dec; 65(4):326-7. PubMed ID: 11074567
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased expression of the Fas ligand on peripheral blood mononuclear cells and undetectable levels of soluble Fas ligand in the serum of patients with aplastic anemia and myelodysplastic syndrome.
    Shinohara K; Takahahi T; Nawata R; Oeda E
    Am J Hematol; 1999 Oct; 62(2):124-5. PubMed ID: 10509009
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.
    Feng X; Scheinberg P; Wu CO; Samsel L; Nunez O; Prince C; Ganetzky RD; McCoy JP; Maciejewski JP; Young NS
    Haematologica; 2011 Apr; 96(4):602-6. PubMed ID: 21160069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequent transformation to overt myelodysplastic syndrome in patients with aplastic anemia showing hematopoietic monoclonality at onset].
    Murai K; Numaoka H
    Rinsho Ketsueki; 2000 May; 41(5):391-6. PubMed ID: 10879097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytophotometry of erythrocytes of patients with anemia syndrome].
    Suleĭman S
    Gematol Transfuziol; 1991 Mar; 36(3):34-5. PubMed ID: 2065955
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes.
    Giudice V; Banaszak LG; Gutierrez-Rodrigues F; Kajigaya S; Panjwani R; Ibanez MDPF; Rios O; Bleck CK; Stempinski ES; Raffo DQ; Townsley DM; Young NS
    Haematologica; 2018 Jul; 103(7):1150-1159. PubMed ID: 29674506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes.
    Piedras J; Hernández G; López-Karpovitch X
    Am J Hematol; 1998 Feb; 57(2):113-8. PubMed ID: 9462542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
    Dong XY; Xu CG; Sun GR; Zhang T; Peng J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):198-201. PubMed ID: 15182554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
    Zuo Y; Cheng Y; Zhang L; Qin Y; Luo H
    Hematology; 2019 Dec; 24(1):480-486. PubMed ID: 31210595
    [No Abstract]   [Full Text] [Related]  

  • 11. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
    Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
    Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
    Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan.
    Ko BS; Chang MC; Chiou TJ; Chang TK; Chen YC; Lin SF; Chang CS; Lu YC; Yeh SP; Chen TY; Hwang WS
    Hematology; 2019 Dec; 24(1):247-254. PubMed ID: 30558522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aplastic anemia--case report].
    Schroers R; Hohloch K; Trümper L
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1837. PubMed ID: 12964102
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased HbF levels in dyserythropoiesis.
    Kudo S; Harigae H; Watanabe N; Takasawa N; Kimura J; Kameoka J; Meguro K; Imaizumi M; Kaku M; Sasaki T
    Clin Chim Acta; 2000 Jan; 291(1):83-7. PubMed ID: 10612719
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
    Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
    Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
    Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
    Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral blood lymphocyte subsets and their relation with early response to treatment in patients with low or intermediate risk myelodysplastic syndrome (IPSS score ≤ 1.0) and chronic aplastic anemia].
    Zhang MY; Ma J; Sun H; Xie XS; Wang C; Liu S; Li T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):377-81. PubMed ID: 24763008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.